The Value of Adjuvant Radiotherapy in Pulmonary and Chest Wall Resection for Bronchogenic Carcinoma

G. A. Patterson, R. Ilves, R. J. Ginsberg, J. D. Cooper, T. R.J. Todd, F. G. Pearson

Research output: Contribution to journalArticlepeer-review

97 Scopus citations

Abstract

Thirty-five patients, 29 men and 6 women, underwent pulmonary and chest wall resection for treatment of bronchogenic cancer which had extended into the chest wall. Anterior chest wall resection was performed in 6 patients, lateral resection in 2, and posterior resection in 27. Marlex mesh was employed as a prosthetic material in 13 patients. Radiotherapy was given as part of the planned therapeutic regimen in 13 patients. Three patients (8.5%) died in the postoperative period. There were 21 late deaths. Eleven patients are alive 7 months to 12 years after resection. The overall actuarial survival, including operative mortality, is 38% at 5 years. Actuarial survival of the 13 irradiated patients is 56% at 2 and 5 years. We believe that bronchogenic carcinoma with chest wall involvement is not hopeless, and that resection of the lung and chest wall can be performed with an acceptable mortality rate.

Original languageEnglish
Pages (from-to)692-697
Number of pages6
JournalAnnals of Thoracic Surgery
Volume34
Issue number6
DOIs
StatePublished - Jan 1 1982

Fingerprint

Dive into the research topics of 'The Value of Adjuvant Radiotherapy in Pulmonary and Chest Wall Resection for Bronchogenic Carcinoma'. Together they form a unique fingerprint.

Cite this